Skip to main content
Information for...
Please select
General Use
Patients or Carers
Health Care Professionals in the US
Health Care Professionals outside the US
Journalists
Jobseekers
Press
Contact
Global sites
About Us
Corporate Profile
Our Company
Vision & Values
History
Diversity & Inclusion
Ethics & Compliance
Sustainability
Making More Health
Access to Healthcare
Press
Press Releases
Image Mediapool
Events & Initiatives
Media Contacts
Annual Press Conference
Global Activities
Europe
North America
South America
Asia
Africa
Australasia
Products
Innovation
Research & Development
Research Approach
Research Beyond Borders
Drug Discovery
Open Innovation
Clinical Trials
Overview
Therapeutic Areas
CardioMetabolic
CNS
Immunology & Respiratory
Oncology
Boehringer Ingelheim Venture Fund
Partnering
Our Approach
Overview
What We Offer
Partnering Interests
Overview
How We Engage
Overview
News & Communications
Press Releases
Events
Partnering Newsletter
Contact Us
Human Pharma
Cardiovascular
Stroke Prevention
Acute Ischaemic Stroke
DVT/PE
Reversal of Anti-coagulation
Myocardial Infarction
Hypertension
Oncology
Lung Cancer
Respiratory
Asthma
COPD
IPF
Scleroderma
Central Nervous System
Overview
Metabolic Diseases
Diabetes
IntroDia
Immunology
Overview
Animal Health
Home
About Animal Health Business Unit
Our Responsibility
Press Releases
Biopharma
Careers
Search form
Search 
Information for...
Please select
General Use
Patients or Carers
Health Care Professionals in the US
Health Care Professionals outside the US
Journalists
Jobseekers
We passionately improve health
Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
Annual Report 2017
Our Company
Annual Report 2017: Agility
For over 130 years, Boehringer Ingelheim has continuously undergone change. Read more how agility drives us in our Annual Report 2017.
Read more
on 
Annual Report 2017: Agility
Research Approach
Research & Development
Research Approach
Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.
Read more
on 
Research Approach
Careers
Working at Boehringer Ingelheim – Being part of a global family
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
Read more
on 
Working at Boehringer Ingelheim – Being part of a global family
-
Animal Health: A global leader in disease prevention and treatment
We create the future of animal wellbeing. Through our innovative and ground-breaking solutions our highly-skilled employees support all our customers who raise and deeply care for their animals. 
Read more          
on 
Animal Health: A global leader in disease prevention and treatment
Therapeutic Areas
Cancer Immunology at Boehringer Ingelheim
Scientists at Boehringer Ingelheim are exploring exciting new approaches to turn up the heat on cancer by firing up our immune systems in a tumor-specific manner.
Read more
on 
Cancer Immunology at Boehringer Ingelheim
Play
Pause
Previous
Next
Explore Our Content

        PRESS RELEASE        
07  Nov  2018 at 09:00
Boehringer Ingelheim becomes an official partner to CatCareforLife
Read more          
on 
Boehringer Ingelheim becomes an official partner to CatCareforLife
Ribbon-cutting in Fremont

        PRESS RELEASE        
31  Oct  2018 at 12:00
Boehringer Ingelheim achieves next expansion milestone in biologics production in the US 
Read more          
on 
Boehringer Ingelheim achieves next expansion milestone in biologics production in the US 
Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals

        PRESS RELEASE        
26  Oct  2018 at 11:00
Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals
Read more          
on 
Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals
bvdzero.com

        PRESS RELEASE        
23  Oct  2018 at 15:00
Boehringer Ingelheim announces the winners of 2018 BVDzero Case Awards
Read more          
on 
Boehringer Ingelheim announces the winners of 2018 BVDzero Case Awards
Acute Ischaemic Stroke
Stroke – Risk Factors and Symptoms
What you need to know
Read more          
on 
Stroke – Risk Factors and Symptoms
Taking Cancer on Through Flavour
Oncology
Taking Cancer on Through Flavour
Simple, nutritious recipes for people with cancer
Read more          
on 
Taking Cancer on Through Flavour
Oncology
What does it mean to drug cancer’s “big four”?
Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums
Read more          
on 
What does it mean to drug cancer’s “big four”?
Scleroderma
The little things
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Read more          
on 
The little things
Home:
Homepage
About Us
Corporate Profile
Careers
Global Activities
Innovation
Research
Clinical Trials
Therapeutic Areas
Boehringer Ingelheim Venture Fund
Human Pharma
Cardiovascular
Oncology
Respiratory
Central Nervous System
Metabolic Diseases
Immunology 
Business Units
Prescription Medicine
Animal Health
Global Activities
Africa
Asia
Australasia
Europe
North America
South America
Share
Back To Top
Facebook
Twitter
Youtube
Linkedin
Instagram
Pinterest
Rss
Accessibility Statement
Terms of Use
Data Privacy
Imprint

            © 2010-2018 Boehringer Ingelheim International GmbH. All rights reserved.    
_satellite.pageBottom();